Clinical Trials Sponsored by Rijksoverheid
Total 1 results
-
Wageningen UniversityMaastricht University; RijksoverheidCompleted
Sponsors and Collaborators
- EndoTheia
- Pearl Network
- Phoenix VA Health Care System
- Retina Foundation of Canada
- kıvan çevik kaya
- Bettina Eiger
- Clinic of the International Institute of Postgraduate Education Ministry of Healthcare of the Republic of Kazakhstan
- Alcohol Education and rehabilitation Fund
- Rivus Pharmaceuticals, Inc.
- EXCELYA Bordeaux
- Critical Care Pharmacotherapy Trials Network
- Department of Orthopedics, Norrköping
- Diabetes Research Institute, Munich, Germany.
- Orthopädisch-Unfallchirurgische Praxis Dr Lembeck & Dr Pampel
- Canadian Glycomics Network (GlycoNet)
- Hospital Santos Reyes de Aranda de Duero, Burgos
- Dr. Khaled Ahmed Yassen
- Jinxiang County People's Hospital
- South Texas Health System McAllen
- Merve Şeker
- View Full List
Medical Conditions
- Myocardial Haemorrhage
- Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI)
- Encephalitis, Arbovirus
- Secondary Pulmonary Arterial Hypertension
- Poststroke Fatigue
- 1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy
- Cystic Renal Disease
- Tumor Cell, Circulating
- Deep Neck Space Infections
- Presence / Absence of EBV
- Malignant Pelvic Neoplasm
- Ruptured Achilles Tendon
- Newborn Infants
- Racial Bias
- Dystonic Disorders
- Organic Anion Transporting Polypeptide1B1 (OATP1B1)
- Acute Upper Gastrointestinal Non Variceal Hemorrhage
- Morton's Neuroma
- Fluorescein Angiography
- Acute Rotator Cuff Tear Related to Trauma
- View Full List
Drug Interventions
- Anastrozole
- Tenofovir
- Nicoderm C-Q Transdermal Product
- Sodium Nitroprusside
- Ketamine 0.3 mg/kg at anesthesia induction
- Modified Bolus 5-FU/LV with Irinotecan
- Cetuximab
- Follitropin beta liquid formulation
- Sipuleucel-T
- Visanne (Dienogest, BAY86-5258)
- Tranexamic acid
- 6-Mercaptopurine
- Granulocyte colony-stimulating factor
- Vinorelbine tartrate
- Trastuzumab in combination with SubQ GM-CSF
- PCO371
- Amisulpride Oral Tablet
- 5.0g SRT501
- Percutaneous sirolimus
- 30 mg CVL-231 as slow-release MR formulation
- View Full List
CROs by country
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Chile
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in India
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in United Arab Emirates
- CRO list by country